Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 28, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

What is the patent landscape for Griseofulvin, and when can generics launch?

Griseofulvin is a drug marketed by Perrigo Co Tennessee, Vintage Pharms, Cipla Ltd, Sigmapharm Labs Llc, Sandoz Inc, Actavis Mid Atlantic, and Riconpharma Llc. and is included in eight NDAs.

The generic ingredient in GRISEOFULVIN is griseofulvin, ultramicrosize. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the griseofulvin, ultramicrosize profile page.

Summary for Tradename: GRISEOFULVIN

Suppliers / Packagers: see list8
Bulk Api Vendors: see list49
Clinical Trials: see list5
Patent Applications: see list5,880
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:GRISEOFULVIN at DailyMed

Pharmacology for Tradename: GRISEOFULVIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo Co Tennessee
griseofulvin, microsize
SUSPENSION;ORAL065200-001Mar 2, 2005ABRXNoNo► Subscribe► Subscribe
Actavis Mid Atlantic
griseofulvin, microsize
SUSPENSION;ORAL065394-001Jul 6, 2007ABRXNoYes► Subscribe► Subscribe
Sigmapharm Labs Llc
griseofulvin, microsize
TABLET;ORAL202482-001Oct 22, 2012ABRXNoNo► Subscribe► Subscribe
Riconpharma Llc
griseofulvin, ultramicrosize
TABLET;ORAL204371-001Jan 9, 2014ABRXNoNo► Subscribe► Subscribe
Vintage Pharms
griseofulvin, microsize
SUSPENSION;ORAL065438-001Oct 8, 2010ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Find generic sources and suppliers
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus